120067-47-2

Usage

Structure

Quinolinone ring with a benzoyl group attached to the 6th position

Derivative

of quinolinone

Therapeutic properties

potential anti-inflammatory and anti-cancer activities

Enzyme inhibition

has been investigated for its potential to inhibit the activity of certain enzymes involved in the growth and spread of cancer cells

Antioxidant and neuroprotective effects

has been found to exhibit these effects, making it of interest for pharmaceutical and medicinal research.

Upstream product

• 553-03-7 3,4-dihydro-2(1H)-quinolone 
• 98-88-4 benzoyl chloride 

Downstream Products

• 120067-48-3 6-(phenylhydroxymethyl)-3,4-dihydrocarbostyril 
• 120067-40-5 3,4-dihydro-6-[(1H-imidazol-1-yl)phenylmethyl]-2(1H)-quinolinone 

Relevant academic research and scientific papers

(1H-azol-1-ylmethyl)substituted quinoline derivatives

(1H-azol-1-ylmethyl)substituted quinoline derivatives, compositions containing the same, and methods of treating mammals suffering from disorders which are characterized by an increase proliferation and/or abnormal differentation of epithelial tissues.

3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase

A series of 1H-imidazol-1-yl- and 3-pyridyl-substituted 3,4- dihydroquinolin-2(1H)-ones was designed and synthesized as combined inhibitors of thromboxane (TXA2) synthase and cAMP phosphodiesterase (PDE) in human blood platelets. A number of st

Carbostyril derivatives as combined thromboxane synthetase and cyclic-AMP phosphodiesterase inhibitors

The invention concerns a method of inhibiting both thromboxane synthetase and cyclic-AMP phosphodiesterase in a mammal having a disease characterized by elevated thromboxane levels or an imbalance of prostacyclin/thromboxane levels with a compound of the